Literature DB >> 25288886

A survey of membrane proteins in human serum.

Nguyen Tien Dung1, Phan Van Chi1.   

Abstract

Serum and membrane proteins are two of the most attractive targets for proteomic analysis. Previous membrane protein studies tend to focus on tissue sample, while membrane protein studies in serum are still limited. In this study, an analysis of membrane proteins in normal human serum was carried out. Nano-liquid chromatography-electrospray ionization mass spectrometry (NanoLC-ESI-MS/MS) and bioinformatics tools were used to identify membrane proteins. Two hundred and seventeen membrane proteins were detected in the human serum, of which 129 membrane proteins have at least one transmembrane domain (TMD). Further characterizations of identified membrane proteins including their subcellular distributions, molecular weights, post translational modifications, transmembrane domains and average of hydrophobicity, were also implemented. Our results showed the potential of membrane proteins in serum for diagnosis and treatment of diseases.

Entities:  

Keywords:  NanoLC-ESI-MS/MS; membrane proteins; proteomics; serum

Year:  2012        PMID: 25288886      PMCID: PMC4177280          DOI: 10.4137/PRI.S9374

Source DB:  PubMed          Journal:  Proteomics Insights        ISSN: 1178-6418


Introduction

As the most easily obtained sample from patients, blood plasma is the primary specimen used to diagnose and monitor many diseases. Because changes in certain components of the plasma are indicative of abnormalities in the body system, many researches have been carried out in search for disease biomarkers in the plasma since the early history of clinical study. After proteomics emerged as a major discipline at the end of the 20th century, plasma study was launched in this new research direction, which could potentially analyze hundreds of proteins at the same time, instead of the one-protein study allowed by traditional genetic/biochemical approach. The plasma contains thousands of proteins, including those originating from most, if not all kinds of cells and tissues.1 The plasma is considered one of the most promising proteomes for proteomic research, and many proteomic techniques and methods have been utilized and modified to analyze the human plasma.2 In an early study of human plasma, Pieper et al could identify 325 proteins using two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS).3 Advancements in the field of proteomics in the past decade have assisted plasma studies in both breadth and depth, exemplified by the forming of a human plasma Peptide Atlas by researchers participating in the Plasma Proteome Project of the Human Proteome Organization (HUPO).4 Comparative studies of the plasma have revealed many potential markers and some insights into the mechanisms of tissue specific diseases, such as cancers,5 Alzheimer’s disease,6 and myocardial infarction.7 Membrane proteomics is a highly focused branch of proteomics. Approximately 30% of proteins encoded by the mammalian genome are transmembrane proteins.8,9 Membrane proteins play an important part in many important cellular processes, including cross-membrane transportation, cell adhesion, signal transduction, immune response, etc.10 Due to their roles as transporters, receptors and structural proteins as well as their impacts on intracellular processes, they are the usual candidates for drug development: about 60% of approved drugs target membrane proteins.11 Many membrane proteins were also found to directly associate with various human diseases, such as Alzheimer’s disease, diabetes, Hodgkin’s disease and liver cirrhosis.12 Thus, researches on membrane proteins also hold promises for developments of diagnosis and disease treatment. The recent studies on human and mammalian membrane proteins tend to focus on cell/tissue samples.13–15 Using carbonate extraction, trypsin digestion and NanoLC-MS/MS, a multilaboratory project has been found to profile membrane proteins from mouse liver.16,17 Another study based on similar approaches, more than 200 proteins were detected in pancreatic cancer cells.18 Furthermore, a large number (862) of membrane proteins were identified in the brain cortex.19 However, we have not found any independent research that focus only on membrane proteins in serum. As a subset of the plasma, serum contains thousands of proteins, including the proteins of membrane origin, even though their abundance can be low. In this study, some results of profiling and characterization of membrane proteins in human serum by using combination of NanoLC-ESI-MS/MS methods and bioinformatics tools are shown. The present study was approved by the Ethics Committee of the Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST).

Materials and Methods

Materials

Dithiothreitol (DTT), iodoacetamide (IAA), ammonium bicarbonate, ammonium acetate, trypsin (proteomics sequencing grade), sodium bicarbonate and Triton X-100 were purchased from Sigma- Aldrich (St. Louis, MO, USA). Formic acid (FA) and triflouracetate (TFA) were obtained from Fluka (Fluka Chemie GmbH, Buchs, Switzerland). Acetonitrile (ACN, chromatogram grade) and other chemicals (analytical grade) were obtained from Barker (Pittsburgh, USA). The Bradford assay kit, Aurum serum protein mini kit, acrylamide, bis-acrylamide, urea, glycine, Tris, CHAPS, and SDS were purchased from Bio-Rad (Hercules, CA, USA). All equipment and standard reagents used directly should be clean as necessary.

Sample preparation

Sera from healthy middle-aged individuals (20–40 years old) were supplied by Bach Mai Hospital, Hanoi, Vietnam, and stored at −80 °C until analysis. After that, albumin and IgG were depleted from the samples using the Aurum serum protein mini kit (Bio-Rad Laboratories, Hercules, CA, USA). Briefly, serum protein column was washed with 1 ml of serum protein binding buffer. For each sample, 60 μl of serum was diluted with 180 μl serum protein binding buffer and then, 200 μl of diluted serum was loaded onto the column. Subsequently, the depleted serum – unbound fraction was collected by centrifugation at 10,000 × g for 20 sec. The removal of albumin and IgG was evaluated by 12.6% SDS-PAGE.

In-solution trypsin digestion

The depleted sera containing approximately 30 μg of total protein were dried by vacuum centrifugation and then dissolved in 50 mM NH4HCO3. The samples were reduced by 10 mM dithiothreitol (DTT) at 56°C for 30 min and alkylated by 5 mM iodoacetamide (IAA) at room temperature for 1 hr. Proteins in the samples were digested using trypsin (Sequencing grade, Sigma-Aldrich, St. Louis, MO, USA) at ratio of 1:50 (w/w) enzyme to protein at 37 °C for 12 hrs. The digestion was stopped by formic acid with final concentration of 0.1%.

Nano two-dimensional chromatography and mass spectrometry

Tryptic peptides were dissolved in 0.1% formic acid and loaded onto Strong Cation Exchange (SCX) Chromatography Column (LC Packing, Dionex, The Netherlands) for separation in the first dimension. The second dimension was performed using a C18 Reversed Phase (RP) Column (GraceVydac, Hesperia, CA, USA) with mobile phase consisting of 0.1% formic acid in water (A) and 0.1% formic acid in 85% acetonitrile (B). Peptides were eluted in a linear gradient from 0% to 100% mobile phase B at a flow rate of 0.2 μl/min for 90 min. Tandem mass spectrometry analysis were performed using an ABI QSTAR®XL hybrid quadrupole/TOF MS/MS instrument (Applied Biosystems/MDS Sciex, Ontario, Canada) equipped with a nanoelectrospray source (Protana XYZ manipulator). Positive mode nanoelectrospray was generated from fused-silica PicoTip emitters with a 10 μm aperture (New Objective, Woburn, MA) at 2.5 kV. MS and MS/MS spectra were recorded and processed in IDA mode (Information Dependent Acquisition) controlled by Analyst QS software. The range of the MS full scan was from 200 to 1500 amu followed by MS/MS fragmentation of the three most intense precursor ions. The dynamic ion selection threshold for MS/MS experiments was set to 45 counts.

Identification of membrane proteins

The obtained MS and MS/MS spectra were searched against the NCBInr and the Swiss-Prot protein sequence database using Mascot™ V1.8 software (Matrix Science Ltd., London, UK). The parameters for searching were set as following: enzymatic digestion with trypsin with one potential missed cleavage; a peptide and fragment mass tolerance of ±0.5; carbamidomethyl (cysteine) as fixed modification; oxidation (methionine) as variable modification. Protein identifications were performed using a Mowse scoring algorithm with a confidence level of 95% and with at least two matched peptides. For further verification, proteins were validated using the open-source software MSQuant v 1.5 (http://msquant.sourceforge.net/). Membrane proteins were sorted from total identified serum proteins based on UniProt protein database (http://www.uniprot.org). SOSUI prediction algorithm was used to predict transmembrane domains and average values of hydrophobicity of those membrane proteins.20

Results

Identification of membrane proteins in serum

The major aim of this study is to detect and profile membrane proteins from human serum. With the strategy and methods described above, 217 membrane proteins were detected from 2778 matched peptides (see Table 1, Supplementary Data). It is interesting to note that more than 90% of the identifications were based on 3 or more matched peptides. From the total of 217 identified membrane proteins, 129 proteins have at least one transmembrane domain (TMD) based on SOSUI prediction algorithm (see Table 1, Supplementary Data).

Evaluation of membrane protein molecular weight

The distribution of molecular weights of membrane proteins from serum was shown in Figure 1. Membrane proteins in serum have a wide range of molecular weights. Proteins with molecular weights from 100–200 kDa make up the largest group, accounting for 43% the total of 217 identified membrane proteins. The second most abundant is the group of proteins with molecular weights in the range of 200–300 kDa (26%). It is also notable that several membrane proteins (6%) have molecular weights above 500 kDa.
Figure 1

Distribution of molecular weights of membrane proteins found in human serum.

Note: Membrane protein identifications and molecular weights were obtained from MS and MS/MS data using Mascot software.

Transmembrane domains (TMDs) and average of hydrophobicity

TMD is one of the most distinguished features of membrane proteins. In our study, 129 (59.4%) proteins were predicted to have at least one TMD in the total of 217 membrane proteins according to SOSUI prediction algorithm. The majority of these 129 proteins have one TMD (25 proteins) and two TMDs (40 proteins), but a considerable number have more than 8 TMDs, which are often receptors, transporters or ion channels. In this study, SOSUI prediction algorithm was also used to evaluate the hydrophobicity of membrane proteins from human serum. The average hydrophobicity values of all identified membrane proteins were calculated based on their amino acid sequences. It is notable that almost all proteins have average hydrophobicity values below zero. Only 17 proteins have positive average hydrophobicity values and most of them (16 proteins) are integral membrane proteins or transmembrane proteins. In addition, 7 UniProt annotated membrane proteins could not be analyzed by SOSUI prediction algorithm because their sizes have more than 5000 amino acids.

Subcellular distribution of membrane proteins

The subcellular distribution of 217 identified membrane proteins was determined using UniProt database according to their accession numbers. Analyzing the available information about the identified membrane proteins, we found that, these proteins have a certain distribution or are shuttled between organelles: 119 proteins are from plasma membrane and a range of proteins are from other cell components, such as nucleus (11 proteins), endoplasmic reticulum (16 proteins), Golgi apparatus (23 proteins), and mitochondrion (7 proteins).

Post-translational modifications of membrane proteins

In this study, 359 post-translational modifications (PTMs) of membrane proteins were found in 187 proteins based on UniProt database; the other 30 membrane proteins do not have post translational modifications. Among the total of membrane proteins having PTMs, proteins with one PTM (77 proteins – 41.2%) and two PTMs (66 proteins – 35.3%) are the majority, while proteins with 5 PTMs make up the smallest group (4 proteins – 2.1%). Among 359 modifications found in the identified membrane proteins, phosphorylation was the most common modification, with 136 phosphoproteins. Follow-up was glycosylation, with 96 glycoproteins. The third and fourth common groups were proteins with dilsufide bonds (48 proteins) and acetylation sites (34 proteins). Lipoproteins, palmitoylated proteins, nitrated proteins, ubiquitinated proteins… contributed to a small fraction of proteins with modifications (Fig. 3).
Figure 3

Components of post translational modifications (PTMs) of membrane proteins in human serum.

Notes: A total of 359 PTMs were found in 217 identified membrane proteins. The most common modifications are phosphorylation and glycosylation.

Discussions

In membrane proteomics, former studies are often inclined to use tissue/cell samples. Using membrane protein extraction by organic acid and NanoLC-MS/MS, Da Cruz et al found 182 membrane proteins from mouse liver mitochondrial inner membrane.21 Another study used membrane proteins extraction from pancreatic cancer cells, SDS-PAGE, in-gel digestion and NanoLC-ESI-MS/MS and detected more than 200 proteins.18 In addition, a large number (862) of membrane proteins were found in the brain cortex.19 The difference in the number of detected membrane proteins from various tissue types can be due to the specificity of each tissue, as well as fractionation and enrichment methods of each study. Combining data from four different sources, an early survey of the plasma by Anderson et al found 212 proteins with at least one TMD with multiple origins,1 which is similar to our results. Probably, there might be more membrane proteins in the serum that have not been detected yet because of their low abundance compared to other serum proteins. Phosphorylation and glycosylation are the two most common modifications of protein in animal cells. Phosphorylation modifies the structure and function of many proteins. An upset balance between phosphorylation and dephosphorylation is the cause of many diseases.22 Glycosylation was estimated to be found in over 50% of human proteins,23 and also of interest because some diseases were found to be related to glycan structural alterations.24,25 Our results with the high proportion of phosphoproteins and glycoproteins showed the potential of membrane proteins in serum for diagnosis and treatment of disease.

Conclusion

By using NanoLC-ESI-MS/MS technologies and bioinformatics tools, a data set of 217 membrane proteins from normal human serum was identified. Some characterization such as subcellular distribution, molecular weigh, post translational modification, transmembrane domain (TMD) and average of hydrophobicity of the identified proteins were also given. 129 proteins (59%) have at least one transmembrane domain, and 187 proteins (86%) have post-translational modifications. List of identified membrane proteins in human serum.
Table 1

List of identified membrane proteins in human serum.

No.Accession numberProtein nameScorePeptide matchMolecular weightSubcellular locationPTMHydrophobicity valueTMDs
1Q8TC27A disintegrin and metalloprotease domain 3243590328UnclearDisulfide bond, Glycoprotein, Phosphoprotein−0.3124522
2Q9H2U9A disintegrin and metalloproteinase 735988036UnclearDisulfide bond, Glycoprotein−0.4145892
3Q9BZC7ABC transporter ABCA26116272140MembraneGlycoprotein, Phosphoprotein−0.06521614
4Q8IZY2ABC transporter ABCA7466236328Plasma membrane, Endosome membrane, Golgi apparatus membraneDisulfide bond, Glycoprotein0.05508012
5Q99758ABC34123192862Plasma membranePhosphoprotein0.08902613
6P00519Abl protein463123852Nucleus membraneLipoprotein, Myristate, Phosphoprotein−0.5971690
7O00763Acetyl-CoA carboxylase606281569EndomembranePhosphoprotein−0.2272181
8O00763Acetyl-CoA carboxylase 2546278361EndomembranePhosphoprotein−0.2272181
9O14617Adapter-related protein complex 3 delta 1 subunit variant629145094Golgi apparatus membranePhosphoprotein−0.4917611
10O95996Adenomatosis polyposis coli 24924245966Golgi apparatus membraneUnknown−0.5291350
11Q13813Alpha II spectrin7017285689Extracellular spaceAcetylation, Phosphoprotein−0.7903300
12P02763Alpha-1-acid Glycoprotein 1 precursor903723579UnclearDisulfide bond, Glycoprotein, Lipoprotein, Palmitate, Phosphoprotein−0.5358211
13Q9UHC3Amiloride-sensitive cation channel 3 isoform c48861376Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2653482
14Q07837Amino acid transport protein561179240Plasma membraneDisulfide bond, Glycoprotein−0.4410821
15Q07075Aminopeptidase A5015109689Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.3904911
16Q5Y190Anchor protein537458487Plasma membraneUnknown−0.18803320
17Q96Q91Anion exchanger AE4474105149Plasma membraneGlycoprotein, Phosphoprotein0.14394711
18Q9P2R3ANKHZN547129534Endosome membraneAcetylation−0.1544900
19P02647Apolipoprotein A-I preproprotein2454530759Plasma membraneGlycation, Glycoprotein, Lipoprotein, Palmitate, Phosphoprotein−0.7172280
20Q12797Aspartyl(asparaginyl)beta-hydroxylase; HAAH42386294Endoplasmic reticulum membraneGlycoprotein, Phosphoprotein−0.7881281
21Q86UQ4ATP binding cassette, sub-family A (ABC1), member 135012580524Plasma membraneUnknown−0.01050814
22Q96J66ATP-binding cassette protein C11 isoform A4018151566Plasma membraneGlycoprotein0.19160712
23Q96J66ATP-binding cassette transporter MRP8475155872Plasma membraneGlycoprotein0.19160712
24Q9HC28ATP-binding cassette, sub-family A, member 2 isoform b7739275244Lysosome membraneUnknown−0.06420414
25Q92887ATP-binding cassette, sub-family C (CFTR/MRP), member 23668175237Plasma membraneGlycoprotein, Phosphoprotein0.09106813
26Q9UMD9Autoantigen558154929Plasma membraneDisulfide bond, Glycoprotein, Hydroxylation, Phosphoprotein−0.5730801
27Q13563Autosomal dominant polycystic kidney disease type II protein474110462Endoplasmic reticulum membraneGlycoprotein−0.3285128
28P50851Beige-like protein; CDC4L protein5718320076Plasma membraneAcetylation, Phosphoprotein−0.2018170
29Q76KP1Beta-1,4-N-acetyl-galactosaminyl transferase 43910116954Golgi apparatus membraneGlycoprotein−0.5976910
30Q01082Beta-spectrin4310275259Plasma membraneAcetylation, Glycoprotein, Phosphoprotein−0.7661160
31Q01082Beta-spectrin 2 isoform 2398251948Plasma membraneAcetylation, Glycoprotein, Phosphoprotein−0.7661160
32Q15413Brain ryanodine receptor7324556937Endoplasmic reticulumGlycoprotein−0.2787275
33O14514Brain-specific angiogenesis inhibitor 15114176900Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.3118068
34O60241Brain-specific angiogenesis inhibitor 27011174738Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2119249
35O60242Brain-specific angiogenesis inhibitor 3597176123Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2118639
36Q9HCU4Cadherin EGF LAG seven-pass G-type receptor 2447322214Plasma membraneDisulfide bond, Glycoprotein, Hydroxylation−0.2707518
37Q9NYQ7Cadherin EGF LAG seven-pass G-type receptor 35110362937Plasma membraneDisulfide bond, Glycoprotein, Hydroxylation−0.2712588
38Q9H251Cadherin-23746370095Plasma membraneGlycoprotein, Phosphoprotein−0.1422782
39Q59FJ3Calcium channel, voltage-dependent, N type, alpha 1B subunit498264553UnclearUnknown−0.26496412
40Q9HCF6Calcium-permeable store-operated channel TRPM3b7211180008UnclearUnknown−0.3021956
41Q08499cAMP-specific phoshodiesterase HPDE4D3 variant42676872UnclearPhosphoprotein−0.6740430
42Q96P48Centaurin delta 2 isoform a variant419166159Plasma membrane, Golgi apparatus, MembranePhosphoprotein−0.4225530
43Q15700Channel associated protein of synapse35897896Plasma membraneLipoprotein, Palmitate, Phosphoprotein−0.5193100
44Q96QT4Channel-kinase 16511214583Plasma membranePhosphoprotein−0.2704566
45P51788Chloride channel protein 241899402Plasma membraneUnknown0.13251711
46P00751Complement factor B preproprotein1751386847Plasma membraneAcetylation−0.5010470
47P17927Complement receptor 1388230417Plasma membraneDisulfide bond, Glycoprotein, Pyrrolidone carboxylic acid−0.3200103
48P10606COX5B6417813914Mitochondrion membraneAcetylation−0.2976740
49Q7Z407CUB and Sushi multiple domains 3 isoform 13613414007Plasma membraneDisulfide bond, Glycoprotein−0.2602391
50Q8IY37DEAH (Asp-Glu-Ala-His) box polypeptide 37404130547UnclearUnknown−0.4153850
51Q6IC98Death-inducing-protein491466766Mitochondrion membranePhosphoprotein−0.4318333
52Q14185Dedicator of cytokinesis 1526216208UnclearPhosphoprotein−0.4306170
53Q5VWQ8Disabled homolog 2 interacting protein isoform 2378118547Plasma membranePhosphoprotein−0.5783020
54O75923Dysferlin isoform 8434239254VesiclePhosphoprotein−0.4001451
55P22413Ectonucleotide pyrophosphatase/phosphodiesterase 1366107024Plasma membraneDisulfide bond, Glycoprotein−0.4560001
56Q8WYP5ELYS transcription factor-like protein TMBS62434258191Nuclear membraneAcetylation, Phosphoprotein−0.4487650
57Q541P7EPH receptor B4 precursor354109741Plasma membraneUnknown−0.2355622
58Q15375Ephrin receptor EphA75510113735Plasma membraneGlycoprotein, Phosphoprotein−0.2842682
59Q15375Ephrin receptor EphA7 variant6110113994Plasma membraneGlycoprotein, Phosphoprotein−0.2842682
60P54762Ephrin receptor EphB1 precursor4520111297Plasma membraneGlycoprotein, Phosphoprotein−0.2144312
61P29323Ephrin type-B receptor 23611119128Plasma membraneLipoprotein, Myristate,Palmitate, Phosphoprotein−0.2934602
62Q9NZJ5Eukaryotic translation initiation factor 2-alpha kinase 34811126095Endoplasmic reticulum membraneGlycoprotein, Phosphoprotein−0.4507172
63Q16099Excitatory amino acid receptor 1; kainate receptor subunit EAA1419108529Plasma membraneGlycoprotein−0.0466534
64Q86XX4Extracellular matrix protein FRAS14510453936Plasma membraneGlycoprotein−0.2956082
65Q9NYQ8FAT tumor suppressor 2 precursor447482097Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2496452
66Q6V0I7Fat-like cadherin FATJ protein4310354108Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2629402
67Q9NZM1Fer-1 like protein 36611234737Nuclear membrane, plasma membraneAcetylation, Phosphoprotein−0.4560911
68Q59F30Fibroblast growth factor receptor 4 variant385114772UnclearUnknown0.0173126
69P42345FK506 binding protein 12-rapamycin associated protein 14010290759Golgi membrane, endoplasmic reticulum membrane, mitochondrial outer membraneAcetylation, Phosphoprotein−0.1925860
70Q9Y2I7FYVE finger-containing phosphoinositide kinase6618239581Endosome membraneAcetylation, Phosphoprotein−0.5343660
71Q86SQ6G protein-coupled receptor 123356139868Plasma membraneGlycoprotein−0.3177496
72Q5T848G protein-coupled receptor 158538136886Plasma membraneGlycoprotein, Isopeptide bond, Phosphoprotein, Ubl conjugation−0.4809887
73O75899GABBR2 protein425100861Plasma membraneGlycoprotein, Phosphoprotein−0.1497348
74Q14789Giantin4413377273Golgi apparatus membraneDisulfide bond, Phosphoprotein−0.9368471
75P42261Glutamate receptor type 1427102270Plasma membrane, Endoplasmic reticulum membraneGlycoprotein, Lipoprotein, Palmitate, Phosphoprotein−0.1992275
76Q9Y3R0Glutamate receptor-interacting protein 1465123203Plasma membrane, Endoplasmic reticulum membranePhosphoprotein−0.3625000
77Q14789Golgi antigen gcp372448373440Golgi apparatus membraneDisulfide bond, Phosphoprotein−0.9368471
78Q08378Golgi autoantigen, golgin subfamily a, 36917167765Golgi apparatus membraneAcetylation, Phosphoprotein−0.8347810
79Q08378Golgin-1605716167810Golgi apparatus membraneAcetylation, Phosphoprotein−0.8347810
80Q6PRD1GPR158-like 1 receptor5411260635Plasma membraneGlycoprotein−0.5831017
81Q8WXG9G-protein coupled receptor 986921694181Plasma membraneUnknownToo long0
82Q8IWJ2GRIP and coiled-coil domain-containing 2 isoform a5315196873Golgi apparatus membranePhosphoprotein−0.9188250
83O15068Guanine nucleotide exchange factor DBS374129340Plasma membranePhosphoprotein−0.5520670
84P52272Heterogeneous nuclear ribonucleoprotein M isoform a441377749Plasma membraneAcetylation, Phosphoprotein, Ubl conjugation−0.3416430
85O43166High-risk human papilloma viruses E6 oncoproteins targeted protein E6TP1 alpha; putative GAP protei5912198570Plasma membranePhosphoprotein−0.6718400
86P35523Human ClC-1 muscle chloride channel377109696Plasma membraneUnknown0.03491911
87Q14643Human type 1 inositol 1,4,5-trisphosphate receptor438309942Endoplasmic reticulum membraneGlycoprotein, Phosphoprotein−0.3154486
88Q9HCF6Hypothetical protein7210175211UnclearUnknown−0.3009246
89Q9P1Z9Hypothetical protein4314199652UnclearPhosphoprotein−0.6479962
90A6NI73Immunoglobulin-like transcript 11 protein39427186UnclearDisulfide bond, Glycoprotein−0.2672242
91Q14571Inositol 1,4,5-trisphosphate receptor type 2506311074Plasma membraneAcetylation, Phosphoprotein−0.2667557
92Q6P9B9Integrator complex subunit 5385109239Nucleus membranePhosphoprotein0.1090292
93Q15811Intersectin long form407196293Plasma membraneAcetylation, Phosphoprotein−0.6680430
94Q9H4E7IRF4-binding protein48774422Plasma membraneAcetylation, Phosphoprotein−0.9464350
95Q92508KIAA02335017234888Endoplasmic reticulum membraneGlycoprotein−0.00235723
96Q13023KIAA0311407259702Nucleus membraneUnknown−0.6759820
97Q96P48KIAA0782 protein454145325Plasma membrane, Golgi apparatus membranePhosphoprotein−0.4225530
98Q9Y2H9KIAA0973 protein6134173192Plasma membranePhosphoprotein−0.5693630
99Q96RV3KIAA0995 protein427109401Plasma membraneGlycoprotein−0.28453813
100Q9BZ29KIAA1058 protein427241774Plasma membranePhosphoprotein−0.3492040
101Q5T848KIAA1136 protein491166642Plasma membraneGlycoprotein, Isopeptide bond, Phosphoprotein, Ubl conjugation−0.4809887
102Q5T4S7KIAA1307 protein537188524UnclearAcetylation, PhosphoproteinToo long0
103Q9BZ72KIAA1457 protein4311151395Plasma membranePhosphoprotein−0.4055610
104Q9P1Z9KIAA1529 protein466196058UnclearPhosphoprotein−0.6479962
105Q6KCM7KIAA1896 protein45763937Mitochondrial membraneUnknown−0.0991470
106Q16787Laminin alpha 3 subunit isoform 1457375652UnclearDisulfide bond, Glycoprotein−0.3813680
107P11047Laminin B2 chain547183195UnclearDisulfide bond, Glycoprotein−0.6150420
108Q9Y6N6Laminin gamma 3 chain precursor406177756UnclearDisulfide bond, Glycoprotein−0.4650180
109Q13449LAMP411337798Plasma membraneDisulfide bond, GPI-anchor, Glycoprotein, Lipoprotein, Phosphoprotein−0.2781062
110P42704Leucine-rich PPR-motif containing protein527146306Nuclear inner membraneAcetylation−0.2060970
111Q86UK5Limbin415148825Plasma membraneGlycoprotein−0.4451852
112P50851Lipopolysaccharide-responsive and beige-like anchor protein6310321639Plasma membraneAcetylation, Phosphoprotein−0.2018170
113Q9HCF6Long transient receptor potential channel 37510196157Plasma membraneUnknown−0.3009246
114Q9NZR2Low density lipoprotein receptor related protein-deleted in tumor519534844Plasma membraneDisulfide bond, Glycoprotein−0.4898882
115Q5JRA6Melanoma inhibitory activity family, member 3527214255Endoplasmic reticulum membraneGlycoprotein, Phosphoprotein−0.8874663
116Q86UL8Membrane associated guanylate kinase, WW and PDZ domain containing 2395159454Plasma membranePhosphoprotein−0.6684550
117Q13421Mesothelin45468652Plasma membraneCleavage on pair of basic residues, GPI-anchor, Glycoprotein, Lipoprotein−0.1057142
118A1L467Met proto-oncogene isoform b precursor486157779Plasma membraneUnknown−0.1443882
119Q8IWA4Mitofusin 1 precursor381084892Mitochondrial membraneUnknown−0.2674762
120Q6UVY6Monooxygenase X36963474Endoplasmic reticulum membraneDisulfide bond, Glycoprotein−0.2608482
121Q8WXI7Mucin 16387747071Plasma membraneDisulfide bond, Glycoprotein, PhosphoproteinToo long1
122O75970Multiple PDZ domain protein607222792Plasma membranePhosphoprotein−0.2332030
123Q9NZM1Myoferlin426231092Vesicle membrane, nuclear membrane, plasma membraneAcetylation, Phosphoprotein−0.4560911
124B2RTY4Myosin-IXa549294918UnclearPhosphoprotein−0.6239800
125Q8NFP9Neurobeachin536330066Plasma membranePhosphoprotein−0.1883582
126P21359Neurofibromin isoform 14310322760Plasma membraneDisulfide bond,GPI-anchor, Glycoprotein, Lipoprotein−0.1369504
127Q9H2E3Neuropilin-2b(5)536102975Plasma membraneUnknown−0.4400662
128Q13423Nicotinamide nucleotide transhydrogenase859114564Mitochondrial membraneAcetylation0.29907913
129Q59GR1Niemann-Pick disease, type C1 variant365145931Plasma membraneUnknown0.21644713
130Q13224N-methyl-D-aspartate receptor subunit NR35316168067Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.3883426
131Q13813Nonerythroid alpha-spectrin597284905UnclearAcetylation, Phosphoprotein−0.7903300
132Q9UM47Notch homolog 3438256640Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.3048263
133Q5STG5Notch homolog 4 (Drosophila)517221594UnclearUnknown−0.2871833
134P46531Notch1 preproprotein3811286350Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.4201193
135Q92823NrCAM protein3711144138Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.3796012
136Q8WXH0NUANCE10429801683Nuclear membraneAcetylation, PhosphoproteinToo long0
137Q5VU65Nucleoporin 210 kDa-like isoform 14310211668UnclearGlycoprotein0.0502653
138Q13017p190-B456173000UnclearNitration, Phosphoprotein−0.5923450
139Q5T4S7p60012121580607UnclearAcetylation, PhosphoproteinToo long0
140O60245PCDH7 (BH-Pcdh)c404130999Plasma membraneGlycoprotein, Phosphoprotein−0.3903652
141Q9BXM0Periaxin598155248Plasma membranePhosphoprotein−0.2257360
142O75747Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing gamma polypeptide389167814UnclearPhosphoprotein−0.3224231
143O00443Phosphoinositide 3-kinase439192271Plasma membraneAcetylation, Phosphoprotein−0.3021360
144O00750PI-3 kinase465184101Plasma membranePhosphoprotein−0.3630370
145Q6T4P5Plasticity-related protein 2431279523MembraneGlycoprotein−0.1782736
146O75051Plexin A23713214220Cell membraneGlycoprotein, Phosphoprotein−0.1814683
147Q9Y4D7Plexin-D1489215381Cell membrane, MembraneGlycoprotein−0.1590132
148Q15142Polycystic kidney disease-associated protein575396273Integral to membraneUnknown0.02276014
149Q8TDX9Polycystin-1 L1354319453Integral to membraneGlycoprotein−0.1368567
150P13942Pro-a2(XI)5110160545Cell membraneDisulfide bond, Glycoprotein, Sulfation−0.8051860
151P08123Pro-alpha 2(I) collagen519129858Plasma membraneGlycoprotein, Hydroxylation, Pyrrolidone carboxylic acid−0.6480980
152P02647Proapolipoprotein6647528944Plasma membraneGlycation, Glycoprotein, Lipoprotein, Palmitate, Phosphoprotein−0.7172280
153Q07954Prolow-density lipoprotein receptor-related protein 16613523119Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.5103862
154Q05655Protein kinase C-delta 1337478624Plasma membranePhosphoprotein−0.3779580
155Q8TF72Protein Shroom 3418218125Plasma membranePhosphoprotein−0.8016520
156Q96QU1Protocadherin 155913217261Plasma membranePhosphoprotein−0.2454732
157Q96QU1Protocadherin 15 isoform CD1-4 precursor4812217303Plasma membranePhosphoprotein−0.2454732
158Q9UN70Protocadherin 4345598230Plasma membraneGlycoprotein−0.2616702
159Q14517Protocadherin Fat 1529509384Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2949462
160Q9NYQ8Protocadherin Fat 2597482172Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein−0.2496452
161Q86V60PTPRM protein398158434UnclearUnknown−0.3855401
162Q8WZA2RAPGEF4 protein5313100339UnclearPhosphoprotein−0.3339270
163P23467Receptor-type tyrosine-protein phosphatase beta5026225497Plasma membraneGlycoprotein, Phosphoprotein−0.3721592
164Q13332Receptor-type tyrosine-protein phosphatase S439218155Plasma membraneDisulfide bond, Glycoprotein−0.4017982
165Q86UR5Regulating synaptic membrane exocytosis 1406190154Plasma membranePhosphoprotein−0.9224590
166Q5T4S7Retinoblastoma-associated factor 60012420580547UnclearAcetylation, PhosphoproteinToo long0
167Q5T5U3Rho GTPase-activating protein 21418218567Golgi apparatus membrane, vesicle membranePhosphoprotein−0.8273380
168Q13464Rho-associated, coiled-coil containing protein kinase 1486159102Golgi apparatus membraneUnknown−0.9094540
169Q5T5U3Rho-GTPase activating protein 10415218563Golgi apparatus membrane, vesicle membranePhosphoprotein−0.8273380
170Q5JTH9Ribosomal RNA processing 12 homolog (S. cerevisiae)569145067Nuclear membranePhosphoprotein−0.2253661
171Q86UR5RIM long form487164927Plasma membranePhosphoprotein−0.9224590
172P21817Ryanodine receptor 1611155204Endoplasmic reticulum membraneGlycoprotein, Phosphoprotein−0.3143007
173Q92736Ryanodine receptor 27010569626Plasma membraneGlycoprotein, Phosphoprotein−0.3243007
174Q15413Ryanodine receptor 37124557794Endoplasmic reticulum membraneGlycoprotein−0.2787275
175O15027SEC16 homolog A365115891Endoplasmic reticulum membrane, Golgi apparatus membraneAcetylation, Phosphoprotein−0.6066070
176A4QN19SEC16A protein402116196Endoplasmic reticulum membrane, Golgi apparatus membraneAcetylation, Phosphoprotein−0.6066070
177Q9H2E6Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A364115608Plasma membraneDisulfide bond, Glycoprotein−0.4485432
178O94921Serine/threonine protein kinase PFTAIRE-141853609Plasma membranePhosphoprotein−0.4703620
179Q8NGB0Seven transmembrane helix receptor4910157779UnclearUnknown−0.2750696
180Q9Y566SH3 and multiple ankyrin repeat domains protein 1497225738Plasma membranePhosphoprotein−0.5392390
181Q9UPX8SH3 and multiple ankyrin repeat domains protein 2546135115Plasma membraneGlycoprotein, Phosphoprotein−0.6085720
182Q7Z5N4Sidekick-like protein 1394242926Plasma membraneDisulfide bond, Glycoprotein−0.3141441
183P21817Skeletal muscle ryanodine receptor789570517Plasma membraneGlycoprotein, Phosphoprotein, S-nitrosylationToo long0
184O94813Slit homolog 24713175803Plasma membraneDisulfide bond, Glycoprotein−0.3234140
185O94813SLIT2407175329Plasma membraneDisulfide bond, Glycoprotein−0.3234140
186Q9C0H9SNAP-25-interacting protein426127182Plasma membranePhosphoprotein−0.6444560
187Q9Y6M7Sodium bicarbonate cotransporter2448115215Plasma membraneGlycoprotein, Phosphoprotein−0.13072510
188Q53ZR1Solute carrier family 12 (sodium/potassium/chloride transporters), member 26413132048Plasma membraneUnknown0.06972011
189Q9HBR0Solute carrier family 38, member 10 isoform b40584069UnclearPhosphoprotein−0.36371811
190Q9NRC6Spectrin beta chain, brain 47214419259UnclearUnknown−0.5765880
191Q01082Spectrin, beta, non-erythrocytic 1 isoform 1 variant488276797Plasma membraneAcetylation, Glycoprotein, Phosphoprotein−0.7661160
192Q8WWQ8Stabilin 2 precursor579288323Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein, Proteoglycan−0.2685632
193Q8WWQ8Stabilin-2469288329Plasma membraneDisulfide bond, Glycoprotein, Phosphoprotein, Proteoglycan−0.2685632
194Q8IVL0Steerin3 protein375256885Nuclear membranePhosphoprotein−0.6387840
195Q4LDE5Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 15210401915UnclearDisulfide bond, Glycoprotein−0.3205281
196Q9Y4G6Talin-25011273723Plasma membraneAcetylation, Phosphoprotein−0.2184120
197Q9H2K2Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2414128492Golgi apparatus membraneADP-ribosylation−0.3170660
198O60343TBC1 domain family, member 4365148068Plasma membranePhosphoprotein−0.5530831
199Q15643Thyroid receptor-interacting protein 11387228184Golgi apparatus membranePhosphoprotein−0.8435060
200P12270Tpr5410265840Nuclear membraneAcetylation, Phosphoprotein−0.9687260
201Q9BX84Transient receptor potential cation channel subfamily M member 6 variant c7920232975UnclearPhosphoprotein−0.3698825
202Q8N6Q1Transmembrane and coiled-coil domains 5A47534495UnclearUnknown−0.5638881
203O95271TRF1-interacting ankyrin-related ADP-ribose polymerase4712143690Golgi apparatus membraneADP-ribosylation, Phosphoprotein−0.3275060
204Q15643Trip2309212228116UnclearPhosphoprotein−0.8435060
205Q9BX84Truncated transient receptor potential cation channel subfamily M member 6 variant a5713224977Plasma membranePhosphoprotein−0.3698825
206Q8NFA0Ubiquitin specific protease 32478183821UnclearLipoprotein, Phosphoprotein, Prenylation−0.4746890
207P55916Uncoupling protein 3 isoform UCP3S361530219Mitochondrion membraneUnknown0.0746790
208P17927Unnamed protein product4110230401Plasma membraneDisulfide bond, Glycoprotein, Pyrrolidone carboxylic acid−0.3200103
209P53420Unnamed protein product6510126774Vesicle membraneAcetylation, Phosphoprotein−0.6592311
210P11717Unnamed protein product4814281089Plasma membraneAcetylation, Disulfide bond, Glycoprotein, Phosphoprotein−0.3685283
211Q6ZUB1Unnamed protein product3610158870UnclearGlycoprotein−0.7092051
212O75110Unnamed protein product3910108198UnclearPhosphoprotein0.0621789
213Q9NRW7Vacuolar protein sorting41665388Endosome membrane, Golgi apparatus membraneUnknown−0.3105260
214Q86Y38Xylosyltransferase I4112108357Endoplasmic reticulum membrane, Golgi apparatus membraneDisulfide bond, Glycoprotein−0.5405640
215Q13433Zinc transporter ZIP641584685Plasma membraneGlycoprotein, Phosphoprotein−0.4219876
216Q13439256 kD golgin599256666Golgi apparatus membranePhosphoprotein−1.0529810
217Q8N1I0Dedicator of cytokinesis protein 44911225206EndomembranePhosphoprotein−0.3714640
  25 in total

1.  Do more complex organisms have a greater proportion of membrane proteins in their genomes?

Authors:  T J Stevens; I T Arkin
Journal:  Proteins       Date:  2000-06-01

Review 2.  Membrane proteins and proteomics: un amour impossible?

Authors:  V Santoni; M Molloy; T Rabilloud
Journal:  Electrophoresis       Date:  2000-04       Impact factor: 3.535

Review 3.  The application of mass spectrometry to membrane proteomics.

Authors:  Christine C Wu; John R Yates
Journal:  Nat Biotechnol       Date:  2003-03       Impact factor: 54.908

Review 4.  Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.

Authors:  G Durand; N Seta
Journal:  Clin Chem       Date:  2000-06       Impact factor: 8.327

Review 5.  Proteomics and the dynamic plasma membrane: Quo Vadis?

Authors:  Richard R Sprenger; Ole N Jensen
Journal:  Proteomics       Date:  2010-11-02       Impact factor: 3.984

6.  Prediction of the human membrane proteome.

Authors:  Linn Fagerberg; Kalle Jonasson; Gunnar von Heijne; Mathias Uhlén; Lisa Berglund
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

7.  Protein glycosylation: new challenges and opportunities.

Authors:  Chi-Huey Wong
Journal:  J Org Chem       Date:  2005-05-27       Impact factor: 4.354

8.  SOSUI: classification and secondary structure prediction system for membrane proteins.

Authors:  T Hirokawa; S Boon-Chieng; S Mitaku
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

9.  Proteomic mapping of brain plasma membrane proteins.

Authors:  Peter Aa Nielsen; Jesper V Olsen; Alexandre V Podtelejnikov; Jens R Andersen; Matthias Mann; Jacek R Wisniewski
Journal:  Mol Cell Proteomics       Date:  2005-01-30       Impact factor: 5.911

10.  Proteome-based plasma biomarkers for Alzheimer's disease.

Authors:  A Hye; S Lynham; M Thambisetty; M Causevic; J Campbell; H L Byers; C Hooper; F Rijsdijk; S J Tabrizi; S Banner; C E Shaw; C Foy; M Poppe; N Archer; G Hamilton; J Powell; R G Brown; P Sham; M Ward; S Lovestone
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

View more
  3 in total

1.  A Routine 'Top-Down' Approach to Analysis of the Human Serum Proteome.

Authors:  Arlene M D'Silva; Jon A Hyett; Jens R Coorssen
Journal:  Proteomes       Date:  2017-06-06

2.  The Role of GPR120 Receptor in Essential Fatty Acids Metabolism in Schizophrenia.

Authors:  Joanna Rog; Anna Błażewicz; Dariusz Juchnowicz; Agnieszka Ludwiczuk; Ewa Stelmach; Małgorzata Kozioł; Michal Karakula; Przemysław Niziński; Hanna Karakula-Juchnowicz
Journal:  Biomedicines       Date:  2020-07-24

3.  Angiotensin(1-7) activates MAS-1 and upregulates CFTR to promote insulin secretion in pancreatic β-cells: the association with type 2 diabetes.

Authors:  Xue-Lian Zhang; Xinyi Zhao; Yong Wu; Wen-Qing Huang; Jun-Jiang Chen; Peijie Hu; Wei Liu; Yi-Wen Chen; Jin Hao; Rong-Rong Xie; Hsiao Chang Chan; Ye Chun Ruan; Hui Chen; Jinghui Guo
Journal:  Endocr Connect       Date:  2022-01-11       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.